
AstraZeneca agrees to buy cancer biotech pioneer for up to $1bn
Britain’s biggest pharmaceuticals company has agreed to acquire a biotech company that it believes can transform cell therapy for up to $1 billion. AstraZeneca has reached a deal with EsoBiotec, a Belgium-based company developing a technology that could …